As the Director of Market Access Strategy for New Products & Business Development (NP&BD) for the assigned therapeutic area, Director will help to shape Janssen’s scientific pipeline by optimizing for greater access when these therapies launch. This is a key role on Janssen’s Value, Access, and Pricing (VAP) team which will integrate key capabilities in the early pipeline to shape success with Market Access (MA) customers in the U.S. market.
Given the increasing complexity of the Access environment, the advanced compounds in the Janssen pipeline and the active business development environment, there are critical decisions made early that shape commercial success of compounds. These disruptive innovations require rethinking of value articulation and new considerations on how therapies fit within systems of care.
This position will be a key member of the cross-functional U.S. Regional Core Strategy Team (RCST) which includes NP&BD, Medical, Brand, and Value & Evidence teams. Director will advise on all pipeline compounds, line extensions, and indication expansions from Discovery through Phase 3 development and label submission. You will integrate a Market Access perspective into key pipeline decisions to support optimal payer coverage and patient access for new pipeline products when in market.
Child care benefits
Short term disability